Glypican-3 is overexpressed in human hepatocellular carcinoma. (Q53654099)

16 May 2018

title

Glypican-3 is overexpressed in human hepatocellular carcinoma. (English)

1 reference

16 May 2018

1 reference

Young Kwan Sung

1

1 reference

16 May 2018

Sun Young Hwang

2

1 reference

16 May 2018

Mi Kyung Park

3

1 reference

16 May 2018

Mohammad Farooq

4

1 reference

16 May 2018

In Sook Han

5

1 reference

16 May 2018

Han Ik Bae

6

1 reference

16 May 2018

Jung-Chul Kim

7

1 reference

16 May 2018

Moonkyu Kim

8

1 reference

16 May 2018

publication date

1 March 2003

1 reference

16 May 2018

published in

Cancer Science

1 reference

16 May 2018

volume

94

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

259-262

1 reference

16 May 2018

Identification of a new membrane-bound heparan sulphate proteoglycan

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Glypican-3 expression is silenced in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Use of a cDNA microarray to analyse gene expression patterns in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Plunc, a member of the secretory gland protein family, is up-regulated in nasal respiratory epithelium after olfactory bulbectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Activation of promoters for cellular lipogenic genes by hepatitis B virus large surface protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

Glypicans: proteoglycans with a surprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01430.X

10.1111/J.1349-7006.2003.TB01430.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

12824919

1 reference

16 May 2018